The XIII Foresight Training Course (FTC) will be held virtually on 23 October 2020.
Annually, Fondazione Gianni Benzi organises the Foresight Training Course (FTC), a short international course aimed to promote pharmacological research and innovation. This year, due to the COVID-19 restrictions enforced, the XIII FTC will run virtually in a shorter version and will be focused on how the pandemic crisis forced the European Regulatory Pharmaceutical System to change.
The event will provide the occasion to discuss the proposed European Union (EU) new strategy, just launched in the pandemic framework, that aims to improve and accelerate patients’ access to high-quality, safe and affordable medicines and to support further innovation in the European pharmaceutical industry.
The first session of the course will exactly address this new European strategy, giving way to the Health Authorities and Regulators as well as to different stakeholders involved in the announced revolution of the EU Pharmaceutical System.
Experts from companies, healthcare professionals, researchers and patients’ groups will share their contribution representing the key points to be discussed during the meeting. The EU pharmaceutical debate includes the proposal to revise two main EU Pharmaceutical System pillars: the Orphan Medicines Regulation and the Paediatric Regulation, that will be deeply considered in a dedicated window of the meeting in order to discuss possible improvement and administrative simplification without reducing their relevance for patients, companies and researchers.